Dr. Christos Vaklavas, MD
- Medicare services, 2024
- 485
- Medicare patients, 2024
- 136
- Part D claims, 2024
- 556
- MIPS score, 2024
- 90
- Hospital affiliations
- 2
- Practice address
- 50 North Medical Drive, Salt Lake City, UT 84132
- Practice phone
- Call (801) 581-2337
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University of Utah Hospitals and Clinics - Unit
Acute Care Hospital-Unit · Salt Lake City, Utah
Find Dr. Vaklavas' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Christos Vaklavas is a hematologist and oncologist in Salt Lake City, Utah
Dr. Vaklavas practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.
Dr. Vaklavas' NPI, 1154649440, was assigned on May 11, 2010. Dr. Vaklavas holds Alabama license 30429.
- NPI
- 1154649440NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9638315146
- NPI enumeration date
- May 11, 2010
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (801) 581-2337
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Christos Vaklavas practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah
Dr. Vaklavas' primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.
- University of Utah Hospitals and Clinics - Unit50 North Medical Drive, Salt Lake City, UT 84132 · Salt Lake CountyPhone(801) 581-2337
Source: Dmand AI Affiliation Data
Dr. Christos Vaklavas is affiliated with 3 sites of care and 1 medical group
Dr. Vaklavas' primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Vaklavas is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Vaklavas to 1 more group practice or clinic, named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Christos Vaklavas' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaklavas practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University of Utah Hospitals and Clinics - Unit | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Christos Vaklavas is one of 88 hematologists and oncologists in Utah
Hematology and oncology is Dr. Vaklavas' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vaklavas is licensed in Alabama.
Specialties and state licenses
- Hematology and oncology, AlabamaPrimary
Hematologists and oncologists near Dr. Vaklavas
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Christos Vaklavas billed Medicare for 485 services in 2024
CMS data shows 485 Medicare services from Dr. Vaklavas across 5 procedure codes in 2024, for 136 Medicare patients. Medicare paid $27,122 for them.
Dr. Vaklavas' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 202024: 2551175%
- Office and hospital visits
- 2023: 1972024: 23017%
Where Dr. Vaklavas' Medicare services took place, 2024
- In an office21344%
- In a facility27256%
Dr. Vaklavas compared with the Utah median for hematologists and oncologists, 2024
- Dr. Vaklavas
- Utah median
- Medicare services
- 485vs 60720% below
- Medicare patients
- 136vs 12211% above
- Part D claims
- 459vs 28660% above
Medians across 91 hematologists and oncologists in Utah with Dmand AI profiles that report each measure.
Dr. Vaklavas' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Vaklavas?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vaklavas and other hematologists and oncologists in Utah.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Christos Vaklavas treated 136 Medicare patients in 2024, average age 72
CMS counts 136 Medicare patients who saw Dr. Vaklavas in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have cancer, and 59% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Vaklavas' median patient age at 71, with 97% women.
Dr. Vaklavas' Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Vaklavas' Medicare patients, 2024
- Cancer75%
- High blood pressure59%
- High cholesterol54%
- Arthritis40%
- Mood disorders34%
- Depression33%
- Anxiety30%
- Diabetes24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Vaklavas' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women97%
- Men3%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Christos Vaklavas wrote 556 Medicare Part D claims in 2024
In 2024, Dr. Vaklavas wrote 556 Medicare Part D claims for 124 patients. 90% of them were for generic drugs. CMS names the drug for 459 of them, across 13 drugs with 11 or more claims each, at $253,577 in total drug cost. In 2023, CMS named 349 claims across 7 drugs.
Dr. Vaklavas' Part D claims by kind of drug, 2024
- Generic499 claims90%
- Brand-name57 claims10%
Dr. Vaklavas' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3492024: 45932%
Drugs named by CMS: 13 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Christos Vaklavas scored 90 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Vaklavas for performance year 2024, reported as part of a group. Dr. Vaklavas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Vaklavas' MIPS scores, performance year 2024
- 90of 100Final score
- 91.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Christos Vaklavas received $98,251 in industry payments from 2016 to 2025
CMS Open Payments shows 162 general payments to Dr. Vaklavas from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. AstraZeneca Pharmaceuticals LP paid the most, $19,565.
General payments to Dr. Vaklavas by program year, 2016 to 2025
General payments to Dr. Vaklavas by kind, 2016 to 2025
- Consulting fees$76,86978%
- Food and beverage$7,6468%
- Honoraria$5,4146%
- Travel and lodging$4,8975%
- Other$3,2953%
Companies that paid Dr. Vaklavas the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Christos Vaklavas's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Christos Vaklavas
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Christos Vaklavas' NPI number?
Dr. Christos Vaklavas' NPI number is 1154649440. It was assigned on May 11, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. Christos Vaklavas?
Dr. Christos Vaklavas is a hematologist and oncologist in Salt Lake City, Utah. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Christos Vaklavas practice?
Dr. Vaklavas practices at 50 North Medical Drive, Salt Lake City, UT 84132. Dr. Vaklavas' primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dmand AI also links Dr. Vaklavas to 1 group practice or clinic.
What is Dr. Christos Vaklavas' office phone number?
The practice phone on file for Dr. Vaklavas is (801) 581-2337.
What is Dr. Christos Vaklavas' medical license number?
Dr. Vaklavas holds Alabama license 30429.
Which hospitals is Dr. Christos Vaklavas affiliated with?
Dr. Vaklavas is affiliated with University of Utah Hospital. Dmand AI links Dr. Vaklavas to 1 more hospital.
What medical group is Dr. Christos Vaklavas part of?
Dr. Vaklavas is linked to University of Utah Health.
Does Dr. Christos Vaklavas accept Medicare?
Yes. CMS data shows Dr. Vaklavas billed Medicare for 485 services in 2024, and Dr. Vaklavas accepts Medicare assignment.
What is Dr. Christos Vaklavas' MIPS score?
Dr. Vaklavas' MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.
How many Medicare patients does Dr. Christos Vaklavas see?
CMS counts 136 Medicare patients who saw Dr. Vaklavas in 2024, with an average age of 72.
Show 4 more questionsShow fewer questions
What services does Dr. Christos Vaklavas bill to Medicare?
In 2024, Dr. Vaklavas' most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and medicare service (G2212).
What drugs does Dr. Christos Vaklavas prescribe most?
In 2024 Medicare Part D data, Dr. Vaklavas' most prescribed drugs by claims were Anastrozole, Exemestane and Letrozole.
Has Dr. Christos Vaklavas received payments from drug or device companies?
CMS Open Payments shows $98,251 in general payments to Dr. Vaklavas from 27 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Christos Vaklavas been practicing?
Dr. Vaklavas graduated from medical school in 2000, 26 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in Utah by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card